T
The420Guy
Guest
The National Health Service (NHS) could be prescribing pain-relieving drugs
derived from cannabis within two years, the Department of Health (DoH) has
announced. Hundreds of UK sufferers from multiple sclerosis are already
being treated with cannabis-based medicines in clinical trials funded by
the Medical Research Council.
Ministers have promised to recommend that the Medicines Control Agency
licenses the treatments if the success of earlier experiments is repeated.
Now the DoH is asking the National Institute for Clinical Excellence (NICE)
to investigate whether the NHS could make the drugs available on prescription.
Guidance
The results of the Medical Research Council's trials are expected by the
end of the year and will be used by NICE in carrying out its appraisal of
the drugs.
A decision on whether any of the cannabis derivatives being tested will be
licensed for official medical use is thought "likely" some time in 2004 or
2005.
The department says the NHS would need "timely and clear guidance" from
NICE on the cost-effectiveness of the treatments and which patients would
benefit most.
Health Minister Lord Hunt said: "If these pharmaceuticals are licensed for
medical use, it is of critical importance that NICE guidance is in place
for the clinicians who will have to make decisions about their use."
Newshawk: puff_tuff
Pubdate: Mon, 18 Feb 2002
Source: BBC News (UK Web)
Copyright: 2002 BBC
Contact: BBC NEWS | Talking Point | Forum
Website: Home - BBC News
Details: MapInc
derived from cannabis within two years, the Department of Health (DoH) has
announced. Hundreds of UK sufferers from multiple sclerosis are already
being treated with cannabis-based medicines in clinical trials funded by
the Medical Research Council.
Ministers have promised to recommend that the Medicines Control Agency
licenses the treatments if the success of earlier experiments is repeated.
Now the DoH is asking the National Institute for Clinical Excellence (NICE)
to investigate whether the NHS could make the drugs available on prescription.
Guidance
The results of the Medical Research Council's trials are expected by the
end of the year and will be used by NICE in carrying out its appraisal of
the drugs.
A decision on whether any of the cannabis derivatives being tested will be
licensed for official medical use is thought "likely" some time in 2004 or
2005.
The department says the NHS would need "timely and clear guidance" from
NICE on the cost-effectiveness of the treatments and which patients would
benefit most.
Health Minister Lord Hunt said: "If these pharmaceuticals are licensed for
medical use, it is of critical importance that NICE guidance is in place
for the clinicians who will have to make decisions about their use."
Newshawk: puff_tuff
Pubdate: Mon, 18 Feb 2002
Source: BBC News (UK Web)
Copyright: 2002 BBC
Contact: BBC NEWS | Talking Point | Forum
Website: Home - BBC News
Details: MapInc
